Jak Knowles und Ceo - Info zur Person - Personensuche Yasni.de

(1 - 9 von 34

)

Cell therapy biotech Affini-T gets $175M; KRAS is lead genomic ...medcitynews.com ›

medcitynews.com

· ... mutations that enable tumors to grow and spread,” Jak Knowles, Affini-T co-founder, president and CEO said in a prepared statement.

Affini-T: Jak Knowles, CEO - Biomarker - Substackbiomarker.substack.com › affini-t-jak-knowles-ceo

biomarker.substack.com

· Dr. Jak Knowles has been at almost every table in medicine and biotech, including the operating variety. After working as a research ...

Details for Jak Knowles : GABC Boston

gabc-boston.org

Dr. Jak Knowles joined as Vice President Venture Investments with Leaps by Bayer in March of Prior to joining Leaps, Jak served as CEO of CytoSen ...

William Blair and MaidStone Life Sciences Biotech Focus Conferencemaidstonels.com › conference

maidstonels.com

Jak Knowles, M.D.. Co-founder, President & CEO. 10:15 a.m.. Break. 10:25 a.m.. Keynote II: Engineering T-Cells for Enhanced Immunotherapy of Solid Tumors.

Affini-T raises $175M with help from Bayer to develop T-cell treatmentswww.bioworld.com › articles

www.bioworld.com

· Jak Knowles is Affini-T's co-founder, president and CEO. He was co-founder and chief business officer for Metagenomi Inc., of Emeryville, ...

Affini-T: engineering T cells to target oncogenic drivers in solid tumorswww.biocentury.com › article › affini-t-engineering...

www.biocentury.com

· The company is led by Leaps by Bayer veteran Jak Knowles, who is co-founder, president and CEO. The former VP of venture investments at the ...

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Jak Knowles und Ceo Person-Info

Cell therapy biotech Affini-T gets $175M; KRAS is lead genomic ...medcitynews.com ›

Affini-T: Jak Knowles, CEO - Biomarker - Substackbiomarker.substack.com › affini-t-jak-knowles-ceo

Details for Jak Knowles : GABC Boston

William Blair and MaidStone Life Sciences Biotech Focus Conferencemaidstonels.com › conference

Affini-T raises $175M with help from Bayer to develop T-cell treatmentswww.bioworld.com › articles

Affini-T: engineering T cells to target oncogenic drivers in solid tumorswww.biocentury.com › article › affini-t-engineering...

CoverCress Leadership: Executives and Demographics - Zippiawww.zippia.com › covercress-careers › ex...

Juno co-founder launches ambitious new startup with Fred Hutch ...lifesciencewajobs.com › Uncategorized

Latham-Led Cancer Treatment Co. Wraps Up $175M Financingwww.law360.com › articles

Alle Infos zum Namen "Jak Knowles"